与CYP3A4/P-葡萄糖蛋白抑制剂相关的菌素毒性模仿败血症休克
Jinjuta Ngeyvijit1, Sopita Nuansuwan2, Vorakamol Phoophiboon3,4
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Chaophraya Abhaibhubejhr Hospital, Prachin Buri, Thailand.
BMJ case reports
|October 9, 2023
概括
科尔奇辛毒性很少见,但由于药物相互作用,即使有正常的器官功能,也可能严重. 识别这些相互作用是诊断和预防不良结果的关键.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 内部医学 内部医学
背景情况:
- 科尔奇辛在治疗剂量时通常是安全的.
- 药物相互作用可能导致意想不到的菌素毒性.
- 毒性范围从轻微的症状到多器官功能障碍综合征.
研究的目的:
- 突出诊断在区分严重的菌素毒性和败血症休克的挑战.
- 强调药物相互作用的作用,特别是与CYP3A4和P-葡萄糖蛋白抑制剂 (如克拉里胺素) 相互作用的作用,导致菌素的毒性.
- 在没有特定测试的情况下,强调临床怀疑在诊断菌素毒性的重要性.
主要方法:
- 案例报告的呈现方式.
- 对临床表现和实验室发现的审查.
- 对药物相互作用途径 (CYP3A4,P-糖蛋白) 的分析.
主要成果:
- 尽管脏和肝脏清除正常,但发生了严重的胆固醇毒性.
- 同时使用胆固醇与清红素 (一种CYP3A4和P-糖蛋白抑制剂) 被确定为可能的原因.
- 区分科尔奇辛毒性与败血症休克是一个诊断挑战.
结论:
- 药物相互作用是科尔奇辛毒性的一个关键因素,即使器官功能得到保护.
- 高临床怀疑指数对于诊断菌素毒性至关重要,特别是当缺乏特定测试时.
- 迅速识别和管理药物诱导的菌素毒性对于改善患者的治疗结果至关重要.
相关概念视频
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
541
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
541
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13
Heart Failure Drugs: Inotropic Agents
601
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
601
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Anticholinesterase Agents: Poisoning and Treatment
896
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
896


